KaVo Kerr Group

	An event designed for dedicated clinicians interested in a comprehensive approach to 3D imaging integration in their practices, the second annual 

 (3DU), features a lineup of world-class educators.

	Recent updates and additions to this roster include: Highly respected in the dental corporate and education community, President and CEO of Cellerant Consulting Group 

, will be taking on the moderator role, bringing his unparalleled ability to make innovation accessible and help dentists across the technology adoption spectrum get the answers they need to make smart choices. Cited by Dr. Gordon Christensen as “one of the most influential dentists in the country today,”

Related reading: The 5 most commonly asked questions about CBCT

will also offer his unique expertise in internet strategy, emerging technologies, e-learning and digital marketing as they relate to the dental community, speaking from his perspective as a Venturer in Residence at Harvard’s Innovation Lab.

	A new name on the esteemed list of presenters is 

, an international speaker and a key opinion leader in the field of digital dentistry, implantology, and microscope enhanced dentistry. He has built his practice upon digital treatment planning of complex oral rehabilitations. He is a consultant for oral and maxillofacial surgeons, periodontists, and general dentists. In 2015 Dr. AminZadeh founded Implant Genius, an implant treatment planning company based in Vancouver. He is an expert in digital workflow stages from digital record taking, implant treatment planning using implant planning software, implant placement using surgical guides, and custom prosthodontic restorations.

	Held Oct. 7-8, 2016, in Boston, 3DU is hosted by KaVo Kerr Group imaging brands Gendex™, 

™, SOREDEX™ and Instrumentarium™. The 2-day event offers dental professionals an educational environment dedicated to Cone Beam 3D (CBCT) solutions - worth up to 11 CE credits - that will enhance their practice and put them in full control of treatment outcomes.

	In addition to Drs. Shuman and AminZadeh, other speakers include: Lou Graham, DDS, on his Journey to 3D; Gy Yatros, DMD, on 3D Airway Analysis; Kaveh Ghaboussi, DMD, on using 3D for Implant Planning and more; Douglas Chenin, DDS, on Success with surgical guides; Terry Work, DMD, on Simple, Predictable Implant Planning; Lisa Koenig, BCHD, DDS, MS offering Anatomy and Pathology Review; Christine Taxin on Medical Billing and Insurance Reimbursement.

	The complete agenda will dive into the role of 3D in endodontics, reading 3D scans, real life case presentations and software training, and best practices for incorporating 3D into the practice in order to maximize your investment.

	For a limited time, dental professionals can enter to win FREE tuition and a 2-night stay in Boston for the event. Go to 

 for details and additional information about the event.

Articles

Held October 7-8, 2016, in Boston, MA, 3DU is hosted by KaVo Kerr Group imaging brands Gendex™, NOMAD™, SOREDEX™ and Instrumentarium™. The 2-day event offers dental professionals an educational environment dedicated to Cone Beam 3D (CBCT) solutions - worth up to 11 CE credits - that will enhance their practice and put them in full control of treatment outcomes

Dental 3D University updates speaker lineup

	KaVo Kerr Group has centralized its global imaging campaign development to its Wooddale, Ill., office effective immediately.

	This marketing hub will serve as the primary global imaging campaign development group for a number of 

Related reading: Lucy Hobbs Project bestows honors on six women leading the dental industry

	This marketing team will be led by Pankaj Jaggi, promoted to director of global imaging campaign development; Kyle Hansen, promoted to global campaign manager; Jens Hartwich, imaging campaign manager, EMEA; and Creative Director Gary Piper.

	“By creating this global center of imaging marketing excellence we are bringing together exceptional team members to create consistent messaging and brand positioning that will resonate across regional markets and convey our dual commitments to innovation and quality,” said Matt Garrett, global vice president of marketing, KaVo Kerr Group. “We know that sharing best practices between this group will only make us more effective.”

	For more information on the KaVo Kerr Group Imaging brands, visit 

More from KKG: KaVo Kerr Group releases new products at IDS presentation

KaVo Kerr Group has centralized its global imaging campaign development to its Wooddale, Ill., office effective immediately.

KaVo Kerr Group restructures global imaging marketing team

 announced today that it has entered into a definitive transaction agreement to acquire 

Webinar: The dental practice management benefits of cloud-based systems 

Over the past 40 years, Nobel Biocare has established itself as a pioneer in nearly every aspect of implant dentistry - from PI Brânemark’s discovery of osseointegration, to Procera digital prosthetic solutions and treating fully edentulous patients. In doing so, Nobel Biocare has dramatically changed the lives of millions of patients. Implants and prosthetics are one of the most exciting categories in dentistry today, offering a unique opportunity for dental professionals to deliver long-term solutions to women and men who desire a smile that is both beautiful and functional. With the ways in which technology and materials science continue to shape the implant dentistry workflow, bringing Nobel Biocare to the dental platform upholds Danaher’s commitment to be a world leader in dentistry.

Nobel Biocare will be a cornerstone of the dental platform. With the addition of Nobel Biocare, Danaher will be the strongest consumable and equipment player in the dental industry, with sales approaching $3 billion. Dental implants is a $3.5 billion market with attractive long term growth drivers, including an aging population, growing income in high growth markets and low penetration rates of dental implants in most geographies today. With this acquisition, Danaher will have an unmatched position in dental implants with Nobel Biocare in the premium segment and the Implant Direct joint venture in the value segment; the company plans to further invest in both these segments. Nobel Biocare will operate as a stand-alone company within Danaher’s dental platform, maintaining its own brand and identity. Implant Direct will remain as a standalonejoint venture with no change in its go to market strategy.

“We will continue to invest in a wide range of dental technologies and innovations to better serve our customers. Bringing Nobel Biocare’s deep expertise in implant dentistry, digital prosthetics and software solutions together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize and integrate workflows. This will lead to better clinical outcomes, shorter treatment times and fewer office visits to the benefit of patients and dental practitioners,” said Henk van Duijnhoven,Senior Vice President of Danaher’s dental platform. “This combination will further support our business strategy and position our dental business for future growth.”

Danaher’s dental platform reaches 99% of all dental practices through an extensive network of dealer partners as well as direct sales. It will continue its strategy of working closely with its highly valued distribution partners as well as direct sales to maximize market access for all its brands.

“Nobel Biocare’s leadership team has done an outstanding job creating a strong platform for future growth over the last couple of years,” van Duijnhoven added. “Our team is excited to work with CEO Richard Laube and the Nobel Biocare team to build on their efforts toward continued innovation, growth and business improvement. We look forward to welcoming allNobel Biocare’s associates, customers and key opinion leaders to the Danaher team.”

see what Jeff Johnson of RW Baird shares about the enterprise value.

Jeff Johnson of RW Baird shares how Wall Street will see changes in the enterprise value after Nobel Biocare joins with the 

Trending Article: Bringing the dental lab in-house

DHR announced this morning plans to acquire

 leading dental implant provider Nobel Biocare for an enterprise value of $2.2 billion (just under 3x 2013 revenue). Across our list and the broader group of strategic dental players, we would be surprised to see a competing bid and near term we don't foresee meaningful implications for our covered companies from this deal, although DHR's strong equipment presence creates some longer-term issues to watch.

DHR announced plans today to acquire leading dental implant provider Nobel Biocare

 for CHF 17.10 per share, or an enterprise value of $2.2 billion (EV just under 3x based on NOBN's 2013 revenue of ~$750 million). Because DHR is covered at Baird by our industrial analyst Rick Eastman, we will leave thoughts on this deal from DHR's perspective to Rick.

As for implications from this deal on the broader dental landscape

We would be surprised to see a competing bid for NOBN from other strategic names in dental.

 We've discussed in prior notes reasons we didn't believe NOBN was a good fit for HSIC, XRAY or SIRO on our list, while STMN also seemingly ruled out interest recently, leaving few other strategic options, in our view.

From a near/intermediate-term perspective

, we wouldn't expect a major change in competitive dynamics due to this deal. DHR's broad geographic reach and strong presence already in the value segment of dental implants present it with some interesting positives in this deal, but nothing that we think creates incremental challenges for our covered companies. On the positive side, DHR has a history of being price rational, which we'd typically consider a positive in a deal like this. In this case, however, we believe premium dental implant players (including XRAY) will likely continue facing pricing pressure from mid/lower-tier players regardless.

, we believe DHR's strong presence in dental equipment, including in 3D imaging currently (especially with iCAT) and over time potentially in CAD/CAM (with Lythos) represent competitive issues that bear watching. In our view, DHR has a done a good job in recent years marrying the consumables and equipment sides of its dental business, with one (iCAT, Lythos) often helping drive sales of the other (Implant Direct implants, Insignia). We believe DHR might enjoy similar cross-selling synergies in this deal over time that implant manufacturers XRAY and STMN and equipment manufacturer SIRO aren't currently able to match.

Click here to view a full industry update.

 Danaher Corporation announced today that it has entered into a definitive transaction agreement to acquire Nobel Biocare Holding AG, the world leader in implant dentistry.

Nobel Biocare to join Danaher Dental Platform

, partnered with Big Brothers Big Sisters to support their initial launch of the STEMmersion program.

Trending Article: The Insane Pain: How to manage tooth hypersensitivity for your patients

The goal of the STEM program is to expose children in local communities to Science, Technology, Engineering and Math as they are applied in the workplace.

This past Saturday, the Pelton & Crane team engaged 20 children in a two-hour event focused on how STEM topics are essential in the engineering of dental chairs and delivery systems. The children toured the show room, factory and R&D test lab. The last hour of the event was designed as a hands-on experience for the kids, designing catapults and testing them for accuracy and distance.

“This is exactly the type of event that exemplifies the character of KaVo Kerr Group associates. Christina Nunez-Cooley, Greg Jung, Patrick Schultheis, Steven Bohon and Michael Bickers deserve a special thanks for their diligent work in preparing for this event and giving of their time to present on Saturday,” said Matt Garrett, Global Vice President of Marketing, Dental Technologies. “The people who develop KaVo Kerr Group innovations make STEM interesting and exciting in real-world applications, and the dental professionals we serve also have a love of science. If we can do our part to encourage STEM interests in a new generation, that’s a win-win.”

 On August 23, 2014, Pelton & Crane, a member of KaVo Kerr Group, partnered with Big Brothers Big Sisters to support their initial launch of the STEMmersion program.  

Pelton & Crane hosts STEM event in partnership with Big Brothers Big Sisters Organization

 is pleased to announce an expansion of its current 

CustomDirect TM Headquarters and Manufacturing and Design Facility 

The company, which created the “value segment” of the implant industry in 2006, continues to experience record growth in 2014. Recognizing the needs of its associates and customers, Implant Direct will be relocating its current Calabasas operations to new space in its state-of-the-art Thousand Oaks Operations hub. This facility will include Manufacturing, Research & Development, Human Resources, Product Development, Regulatory and Accounting. With this eight mile move from Calabasas to Thousand Oaks, Implant Direct will increase the size of its manufacturing footprint.

Also in anticipation of growth, Implant Direct acquired new space in Valencia, California last year to house its Technical Sales and Customer Support teams. Implant Direct will now be expanding that environment to become its global Sales, Marketing, Education and Technical Service hub. This facility, along with the company’s world-class global education and distribution center in Las Vegas, Nevada, is focused on supporting dental practitioners in bringing the benefits of implant dentistry to their patients. The move is designed to support Implant Direct’s long-term growth plans.

Tom Stratton, President of Implant Direct, stated: “The synergies created through this move will enable us to deliver on our promise of simply smarter implant solutions with even greater agility. We are deeply committed to providing the global dental community with true value – high-quality, innovative solutions at fair prices. Our expanded 45,622 square foot, state-of-the-art manufacturing headquarters in Thousand Oaks will bring technological advancements and cost efficiency by combining our sophisticated manufacturing processes. Our milling equipment can be configured to produce a family of parts (rather than individually), meet demanding tolerances and operate in a lights-out manufacturing environment – thus achieving extraordinary efficiency and quality.”

Implant Direct’s geographic footprint also includes European headquarters in Zurich, Switzerland, Australian headquarters in Sydney, Australia, Israeli headquarters in Tel Aviv, Israel as well as European and Canadian Distribution facilities in Amersfoort, Netherlands and Richmond, British Columbia. Information about Implant Direct locations and its international distribution network is available at 

 Implant Direct is pleased to announce an expansion of its current CustomDirect TM Headquarters and Manufacturing and Design Facility in Thousand Oaks, California.

Implant Direct announces expansion

 is a $2 billion global portfolio of 16 industry-leading brands that serves 99% of dental practices worldwide.

Following the impressive roll out of 20 new products at the 

 Midwinter Meeting this February, the KaVo Kerr Group is now building a Marketing Communications team to manage the stories and opportunities that link these remarkable brands.

 will lead the team as Senior Director for Global Marketing, KaVo Kerr Group. After nearly 20 years in the dental industry, Carsten’s leadership is synonymous with boldness and creativity. His many successes with the 

 brands demonstrate his ability to align product values with the core needs of dental professionals. In this new role, he will bring a global perspective to framing the KaVo Kerr Group story that spans Hygiene, Restorative, Traditional Equipment, Imaging, Specialty and Special Markets.

Joining Carsten in this effort is Thais Carter (

 as Senior Manager for PR/Media Relations, KaVo Kerr Group. Having been at the helm of Dental Products Report for the last five years, Carter is uniquely positioned to help manage the narrative of how each of the brands and products within KaVo Kerr Group are creating value for dental professionals and the patients they serve. Her award-winning editorial background will ensure that the KaVo Kerr Group message is about valuable content and clinical relevance that help dental professionals confidently optimize their work and lives.

“There are so many outstanding stories to be told around the innovations coming out of the KaVo Kerr Group – we owed it to those brands to assemble the best possible team to deliver that message,” 

said Henk van Duijnhoven, president of KaVo Kerr Group globally. 

“Carsten Franke and Thais Carter represent two incredibly original, strategic minds. They will bring purpose and passion to KaVo Kerr Group’s mission to inspire best practices.”

The new team will be working with media outlets to put all KaVo Kerr Group news into meaningful context, improving the conversation around smart dental innovation that matters and empowering dental professionals to confidently employ that innovation.

Click here to learn how to boost your practice's image. 

 The KaVo Kerr Group is a $2 billion global portfolio of 16 industry-leading brands that serves 99% of dental practices worldwide. 

KaVo Kerr Group Appoints Global Marketing Communications Team

Wondering if a KaVo handpiece is for you? You can put them to the test, risk-free, with the 

Here’s how it works: Choose a KaVo handpiece you’d like to try at 

, demo the handpiece in your office for five business days, and then return the handpiece to KaVo – no strings attached.

Here, KaVo Product Manager William Irwin offers five reasons you should Try KaVo for five days:

KaVo is recognized as a leading dental manufacturer worldwide. Our products offer maximum comfort for patients during treatment plus precision and time saving for dental professionals.

Try KaVo is the only program of its kind in the dental industry. Visit 

 and select the KaVo product you want to try.

“The product ships to you, you get to use it for five days, then you drop it in a box and ship it back to KaVo,” Irwin says. KaVo even includes pre-addressed and pre-paid packaging for your return.

Scheduling an appointment with sales representatives every time you want to try a new product can be exhausting. With the Try KaVo program, you can try the products you want without setting aside time for a sales pitch. Plus, you actually get to use your product on live patients in the comfort of your office – no more demos on bones or cutting blocks.

If you’ve ever purchased products online, you can still use the Try KaVo web portal.

“There is a very broad selection of KaVo products- from air driven to electric to hygiene,” Irwin says. “It’s an easy to use checkout process, much like you’d use on Amazon to purchase your products.”

Select the KaVo product you’d like to try, enter your zip code to find a dealer in your area and place your order. Your package will be delivered via FedEx to your office.

“You get it for five days – if you don’t like it or you want to try other KaVo products before making a final purchase, you can send it back,” says Irwin.  “Or at the end of the trial, you can talk to your sales rep about purchasing your KaVo product.”

Wondering if a KaVo handpiece is for you? You can put them to the test, risk-free, with the Try KaVo program.